Related Experiment Video
Updated: Jul 28, 2026

03:55
Computer-Aided Three-Dimensional Visualization in the Treatment of Locally Advanced Thyroid Cancer
Published on: June 9, 2023
Support groups for patients with Graves' disease and other thyroid conditions
1Thyroid Foundation of America, Inc., Boston, Massachusetts, USA.
Endocrinology and Metabolism Clinics of North America
|April 16, 1998
Summary
Thyroid patient organizations offer vital free information and support globally, improving patient understanding and reducing physician workload. Physician referrals and encouragement of financial support can further enhance these crucial patient resources.
Area of Science:
- Endocrinology
- Patient Advocacy
Background:
- Thyroid foundations and associations offer global resources for thyroid patients.
- These organizations enhance patient comprehension and adherence while decreasing anxiety.
- Physician time is conserved through these patient support networks.
Purpose of the Study:
- To highlight the benefits of thyroid patient organizations for both patients and physicians.
- To suggest methods for physicians to collaborate with and support these organizations.
Main Methods:
- Literature review on patient support groups.
- Analysis of physician-patient interactions in endocrinology.
- Case study of thyroid patient advocacy impact.
Main Results:
- Thyroid patient groups improve patient education, compliance, and reduce anxiety.
- Physician time savings and increased patient understanding are key outcomes.
- Direct patient engagement and organizational support are beneficial.
Conclusions:
- Physician collaboration with thyroid patient organizations is mutually beneficial.
- Referrals to and from these groups, alongside financial support encouragement, are recommended.
- Strengthening these networks improves thyroid patient care and outcomes.
Related Concept Videos
The Thyroid Gland
The thyroid gland is a small, butterfly-shaped gland located in the neck and covers the anterior surface of the trachea. The gland has two lateral lobes connected by a thin tissue mass called the isthmus. Internally, each lobe comprises many small spherical structures known as thyroid follicles, surrounded by a network of blood vessels.
The follicles have a central cavity lined by simple cuboidal to squamous epithelial cells called follicular cells. These cells produce the glycoprotein...
The follicles have a central cavity lined by simple cuboidal to squamous epithelial cells called follicular cells. These cells produce the glycoprotein...
Hyperthyroidism I: Introduction
Hyperthyroidism is a type of thyrotoxicosis characterized by the thyroid gland's overproduction of the thyroid hormones triiodothyronine (T3) and thyroxine (T4). This hormone excess increases the basal metabolic rate and enhances sensitivity to catecholamines.DiagnosisDiagnosis is based on clinical features and biochemical testing. It typically shows suppressed thyroid-stimulating hormone (TSH) levels below 0.4 mIU/L, with elevated free T3 and/or T4. Additional tests, including thyroid...
Hyperthyroidism II: Pathophysiology
Hyperthyroidism is a hypermetabolic state caused by elevated levels of thyroid hormones, triiodothyronine (T3) and thyroxine (T4). It results from dysregulation at the thyroid, pituitary, or immune system level and affects multiple organ systems.PathophysiologyThe most common cause of hyperthyroidism is Graves’ disease, an autoimmune disorder in which antibodies, specifically thyroid-stimulating antibodies (TSAb), a subtype of TSH receptor antibodies (TRAb), bind to and activate TSH receptors...
Graves' Disease I: Introduction
Graves' disease is an autoimmune disorder that causes hyperthyroidism, or overactivity of the thyroid gland. It results from autoantibodies called thyroid-stimulating immunoglobulins (TSIs), which bind to thyroid-stimulating hormone (TSH) receptors, leading to overstimulation of hormone production and a hypermetabolic state.EtiologyAlthough considered idiopathic, Graves’ disease has well-established contributing factors. There is a strong genetic component, with increased prevalence in...
Graves Disease II: Pathophysiology
Graves’ disease is an autoimmune disorder characterized by the production of thyroid-stimulating immunoglobulins (TSI) that activate TSH receptors, leading to excessive synthesis and release of thyroid hormones (T3 and T4) and resulting in hyperthyroidism.Among all causes of hyperthyroidism, Graves’ disease is the most common and can happen at any age, though it is more frequent in women. It produces a hypermetabolic state with features such as weight loss, tachycardia, tremor, and heat...
Hypothyroidism II: Pathophysiology
Hypothyroidism is a disorder characterized by insufficient production of thyroid hormones, which regulate metabolism, energy balance, and multiple organ systems.TypesHypothyroidism is classified based on the level of dysfunction. Primary hypothyroidism results from intrinsic thyroid gland dysfunction, causing reduced hormone production despite normal or increased stimulation. Secondary hypothyroidism arises from inadequate thyroid-stimulating hormone (TSH) secretion by the pituitary. Tertiary...

